Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01410201 · ClinicalTrials.gov registry record · NA
Dexamethasone Intravitreal Implant After Vitrectomy For Epiretinal Membrane
A NA study, sponsored by Barnes Retina Institute.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT01410201: Clinical Trial NA study, sponsored by Barnes Retina Institute.
NCT01410201 is a NA study that was terminated before completion, run by Barnes Retina Institute. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01410201, a NA study, was terminated before completion, sponsored by Barnes Retina Institute.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effect of dexamethasone intravitreal implant (Ozurdex) in combination with pars plana vitrectomy and membrane peeling for idiopathic epiretinal membrane (ERM).
Primary Outcome
At all study visits: ETDRS visual acuity will be measured visit excluding post op day 1 (snellen visual acuity will be measured). Intraocular pressure (IOP) will be checked. Spectral Domain Optical Coherence Tomography (OCT). Dilated fundus exam. At Pre Op, Post Op Week 4, 8, 12, 16, 20 and 24 visits: ETDRS visual acuity will be measured. IOP check. Spectral Domain OCT. Fundus photography. Fundus Autofluorescence (AF). Fluorescein Angiography (FA). Dilated Fundus exam.
Interventions
- DRUG Dexamethasone Intravitreal Implant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2011-08 |
| Est. Completion | 2016-01 |
| Phase | NA |
Why NCT01410201 stopped before completion
NCT01410201 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Dexamethasone Intravitreal Implant is the first listed.
NCT01410201 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01410201 about?
NCT01410201 is a clinical study titled "Dexamethasone Intravitreal Implant After Vitrectomy For Epiretinal Membrane". The purpose of this study is to evaluate the effect of dexamethasone intravitreal implant (Ozurdex) in combination with pars plana vitrectomy and membrane peeling for idiopathic epiretinal membrane (ERM).
What is the current status of trial NCT01410201?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2011-08. Estimated completion is 2016-01.
What interventions are being tested in trial NCT01410201?
The interventions under investigation include: Dexamethasone Intravitreal Implant (DRUG).
Who is sponsoring clinical trial NCT01410201?
This trial is sponsored by Barnes Retina Institute, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01410201's enrollment target sits among peer trials
6 1983rd of 2000 higher than 13 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia